Le Lézard
Classified in: Health
Subject: PDT

Cardiovascular Centers of America Announces Cardiac Ablation Service Line at Advanced Heart and Vascular in Deltona, Florida


DELTONA, Fla., April 17, 2024 /PRNewswire/ -- Cardiovascular Centers of America (CCA)  proudly announces the launch of Florida's the first complete cardiac ablation service line in an Ambulatory Surgery Center (ASC) at Advanced Heart and Vascular Surgery Center (Advanced Cardiovascular). The team at Advanced Cardiovascular  successfully performed the inaugural AFIB ablation procedure within a Florida ASC setting in April 2024.

Cardiovascular Centers of America proudly announces the launch of Fla.'s first complete cardiac ablation service line.

The achievement of AFIB Ablations in the ASC setting marks a significant advancement in ASC-based cardiovascular care, ushering in a new era of accessible treatment options for individuals with atrial fibrillation (AFIB) and supraventricular tachycardia (SVT). With millions of Americans annually affected by these heart conditions, this innovative approach promises to revolutionize patient care access and affordability across the region.

In addition to the AFIB milestone, Advanced Cardiovascular is also one of the first ASCs in Florida to perform SVT and AV Node cardiac ablation procedures, providing another vital treatment option. SVT affects an estimated 1.2 million people in the United States while AFIB affects roughly 2.7 to 6.1 million individuals in the United States, with numbers expected to rise due to an aging population and increasing prevalence of risk factors such as hypertension and obesity.

The initial procedures performed by Dr. Huijian (James) Wang, Dr Hanscy Seide, and Dr. Florentino Lupercio, all leading electrophysiologists in Volusia County. Dr. Wang expressed his excitement for these advancements, stating, "Performing the first AFIB ablation in an ASC in Florida is a testament to our dedication to providing proven, patient-centered care in the outpatient environment. We are proud to offer solutions that improve access and outcomes for our patients.

The Advanced Cardiovascular team will be opening a second location in Daytona Beach next month and welcomes patients from across the regions to learn more about the ASC difference. 

Tim Price, the CEO of Cardiovascular Centers of America, emphasized the significance of these achievements, stating, "We are thrilled to support these outstanding physicians and facilities leading the charge to bring state-of-the-art cardiac care centers to patients across Florida. These milestones represent our unwavering commitment to improving patient outcomes and accessibility to advanced cardiovascular treatments."

For more information, please visit www.cardiovascularcenters.com and www.advanceddeltona.com.

Official Spokesperson
Tim Price
CEO, Cardiovascular Centers of America
(678) 642-5118
[email protected]

Media Contact
Kristen McCullough
KAMCOM Media
[email protected]
www.KAMCOMmedia.com

About Cardiovascular Centers of America 

Cardiovascular Centers of America is a leading developer and manager of cardiovascular specialty surgery centers across the United States. CCA is dedicated to bringing high-quality, affordable, patient-centric cardiovascular care to the outpatient ASC setting.

About Advanced Heart and Vascular Surgery Center 

The Advanced Heart and Vascular Surgery Center is the preeminent cardiovascular specialty Ambulatory Surgery Center in Central Florida. The ASC boasts a modern catheterization and EP lab led by a team of expert physicians and exceptional medical staff. Equipped with state-of-the-art technology, Advanced Cardiovascular delivers cutting-edge cardiovascular diagnostics and treatments, ensuring the highest standards of care for every patient they serve.

SOURCE Cardiovascular Centers of America


These press releases may also interest you

at 16:40
TriSalus Life Sciences Inc., , today announced the closing of a debt financing facility for up to $50 million with OrbiMed, a healthcare investment firm. The capital is expected to provide financial flexibility to support the execution of strategic...

at 16:30
Vanda Pharmaceuticals Inc. (Vanda) today announced it will release results for the first quarter 2024 on Wednesday, May 8, 2024, after the market closes....

at 16:30
Community Healthcare Trust Incorporated (the "Company") today announced results for the three months ended March 31, 2024. The Company reported net income for the three months ended March 31, 2024 of approximately $3.7 million, or $0.11 per diluted...

at 16:16
Net income of $395.2 million ($2.04 per diluted common share) for the first quarter of 2024; after-tax adjusted operating income was $409.9 million ($2.12 per diluted common share).Results reflect a growing top-line with core operations premium...

at 16:15
Exelixis, Inc. today reported financial results for the first quarter of 2024, provided an update on progress toward achieving key corporate objectives, and detailed its recent and anticipated commercial, clinical and pipeline development...

at 16:15
Rasmussen University today announced the expansion of its Bloomington Bachelor of Science in Nursing (BSN) program to the Hennepin/Anoka campus. Through this expansion, all Rasmussen University campuses in the Twin Cities area will now offer the...



News published on and distributed by: